Federal Register / Vol. 60, No. 39 / Tuesday, February 28, 1995 / Notices 10865

1Copies of the Complaint and the Decision and

Order are available from the Commission’s Public

Reference Branch, H–130, 6th Street & Pennsylvania

Avenue, NW., Washington, DC. 20580.

No comments having been received,

the Commission has ordered the

issuance of the complaint in the form

contemplated by the agreement, made

its jurisdictional findings, and entered

an order to divest, as set forth in the

proposed consent agreement, in

disposition of this proceeding.

(Sec. 6, 38 Stat. 721; 15 U.S.C. 46. Interpret

or apply sec. 5, 38 Stat. 719, as amended; sec.

7, 38 Stat. 731, as amended; 15 U.S.C. 45, 18)

Donald S. Clark,

Secretary.

[FR Doc. 95–4868 Filed 2–27–95; 8:45 am]

BILLING CODE 6750–01–M

[Docket No. C–3556]

Olsen Laboratories, Inc., et al.;

Prohibited Trade Practices, and

Affirmative Corrective Actions

AGENCY: Federal Trade Commission.

ACTION: Consent order.

SUMMARY: In settlement of alleged

violations of federal law prohibiting

unfair acts and practices and unfair

methods of competition, this consent

order prohibits, among other things, two

Kansas-based firms and an official from

making false claims for Eez-Away, an

arthritis pain treatment, or similar

products. The consent order requires the

respondents to possess competent and

reliable scientific evidence before

making any health or medical benefit

claim for any personal or household

product or service they market in the

future; requires them to clearly identify

any future infomerical they disseminate

as paid advertising; and prohibits them

from misusing endorsements.

DATES: Complaint and Order issued

February 6, 1995.1

FOR FURTHER INFORMATION CONTACT:

Lesley Fair, FTC/S–4002, Washington,

DC, 20580. (202) 326–3081.

SUPPLEMENTARY INFORMATION: On

Thursday, December 1, 1994, there was

published in the Federal Register, 59 FR

61622, a proposed consent agreement

with analysis In the Matter of Olsen

Laboratories, Inc., et al., for the purpose

of soliciting public comment. Interested

parties were given sixty (60) days in

which to submit comments, suggestions

or objections regarding the proposed

form of the order.

No comments having been received,

the Commission has ordered the

issuance of the complaint in the form

contemplated by the agreement, made

its jurisdictional findings and entered

an order to cease and desist, as set forth

in the proposed consent agreement, in

disposition of this proceeding.

(Sec. 6, 38 Stat. 721; 15 U.S.C. 46. Interprets

or applies sec. 5, 38 Stat. 719, as amended;

15 U.S.C. 45, 52)

Donald S. Clark,

Secretary.

[FR Doc. 95–4869 Filed 2–27–95; 8:45 am]

BILLING CODE 6750–01–M

GOVERNMENT PRINTING OFFICE

The Federal Register Online Via GPO

Access; Public Meeting for Federal,

State and Local Agencies, and Others

Interested in a Demonstration of GPO

Access, the Online Service Providing

the Federal Register and Other Federal

Databases

The Superintendent of Documents

will hold two public meetings for

Federal, State and local government

agencies, and others interested in an

overview and demonstration of the

Government Printing Office’s online

service GPO Access, provided under the

Government Printing Office Electronic

Information Access Enhancement Act of

1993 (Pub. L. 103–40).

Two sessions are available on

Tuesday, March 14, 1995, from 9 a.m. to

10:30 a.m. and from 11 a.m. to 12:30

p.m. Both sessions will be held at the

U.S. Government Printing Office, Carl

Hayden Room (eighth floor), 732 North

Capitol Street NW., Washington, DC

20401.

The online Federal Register service

offers access to the daily issues of the

Federal Register by 6 a.m. on the day

of publication. All notices, rules and

proposed rules, Presidential documents,

executive orders, separate parts, and

reader aids are included in the database

as ASCII text files, with graphics

provided in TIFF format. The online

Federal Register is available via the

Internet or as a dial-in service.

Historical data is available from January

1994 forward.

Other databases currently available

online through GPO Access include the

Congressional Record; Congressional

Record Index, including the History of

Bills; Congressional Bills, Public Laws;

and U.S. Code.

Individuals interested in attending

either session should contact the GPO’s

Office of Electronic Information

Dissemination Services, John Berger,

Product Manager, on 202–512–1525;

(FAX) 202–512–1262; or by Internet email at help@eids05.eids.gpo.gov.

Seating reservations will be accepted

through Friday, March 10, 1995.

Michael F. DiMario,

Public Printer.

[FR Doc. 95–4835 Filed 2–27–95; 8:45 am]

BILLING CODE 1505–02–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food and Drug Administration

Statement of Organization, Functions,

and Delegations of Authority

Part H, Chapter HF (Food and Drug

Administration) of the Statement of

Organization, Functions, and

Delegations of Authority for the

Department of Health and Human

Services (35 FR 3685, February 25, 1970

and 56 FR 29484, June 27, 1991, as

amended most recently in pertinent

parts at 51 FR 8032, March 7, 1986) is

amended to reflect the following

reorganization in the Food and Drug

Administration (FDA).

FDA is revising the substructure of

the Office of Public Affairs within the

Office of External Affairs. The purpose

of the revisions is to establish a new

Broadcast Media Staff to manage

broadcast media activities. The

broadcast media functions will be

transferred to the new staff from the

Press Relations Staff, which will

continue to have print media functions.

Under Section HF–B, Organization

1. Delete subparagraph (e–1) Press

Relations Staff (HFAJA) in its entirety

and insert new subparagraphs (e–1)

Press Relations Staff (HFAJA) and (e–6)

Broadcast Media Staff (HFAJG) under

paragraph Office of Public Affairs

(HFAJ) under Office of External Affairs

(HFAQ) reading as follows:

Press Relations Staff (HFAJA)

Advises and assists top level Agency

officials on print press matters involving

mass media communications.

Plans, develops, and implements

Agencywide print media strategies for

disseminating regulatory and

educational materials to the public

through the mass media.

Serves as the Agency focal point for

preparing, clearing, and disseminating

press releases and other print media

statements representing Agency policy

and responding to print media inquiries;

maintains liaison with news media and

pertinent publications.

Establishes policy for and coordinates

all print media information activities,

including news interviews and

responses to inquiries; prepares position
10866 Federal Register / Vol. 60, No. 39 / Tuesday, February 28, 1995 / Notices

and policy statements for use by Agency

employees in responding to print media

questions; tracks issues of potential

interest to the media.

Coordinates the research and drafting

of major public statements by the

Commissioner, including transmittal

documents and supportive statements

for use in transactions with the

Department, other agencies, and the

White House; provides editorial

consultation and review for

manuscripts, articles, and speeches

written by the staff offices serving the

Commissioner to ensure consistency of

information and policy interpretation

and maintains mailing lists for these

documents.

Compiles, publishes, and distributes

the weekly FDA Enforcement Report

and the FDA Public Calendar; maintains

the FDA Daily Clipping Service and

FDA’s electronic bulletin board; and

coordinates the Daily Media Report.

Broadcast Media Staff (HFAJG)

Advises and assists top level Agency

officials on electronic media matters

involving mass media communications.

Plans, develops, and implements

Agencywide broadcast media strategies

for disseminating regulatory and

educational materials to the public

through the mass media.

Serves as the Agency focal point for

preparing, clearing, and disseminating

electronic media requests representing

Agency policy and responding to

electronic media inquiries; maintains

liaison with broadcast media contacts.

Establishes policy for and coordinates

all braodcast media information

activities, including on-camera

interviews and responses to media

inquiries; prepares position and policy

statements for use by Agency employees

in responding to broadcast media

questions; tracks issues of potential

interest to the media.

Plans and coordinates all broadcast

media training for the Agency.

Under Section HF–D, Delegation of

Authority

Pending further delegations,

directives, or orders by the

Commissioner of Food and Drugs, all

delegations of authority to officers or

employees of the Office of Public Affairs

in effect prior to this date shall continue

in effect in them or their successors.

Dated: February 10, 1995.

David A. Kessler,

Commissioner of Food and Drugs.

[FR Doc. 95–4796 Filed 2–27–95; 8:45 am]

BILLING CODE 4160–01–M

National Institutes of Health

Consensus Development Conference

on Cochlear Implants in Adults and

Children

Notice is hereby given of the NIH

Consensus Development Conference on

‘‘Cochlear Implants in Adults and

Children,’’ which will be held May 15–

17, 1995, in the Natcher Conference

Center of the National Institutes of

Health, 9000 Rockville Pike, Bethesda,

Maryland 20892. The conference begins

at 8:30 a.m. on May 15, at 8 a.m. on May

16, and at 9 a.m. on May 17.

Cochlear implants are effective

options in habilitation and

rehabilitation of individuals with

profound hearing impairment. The vast

majority of adults who are deaf and

have cochlear implants derive

substantial benefit from them when they

are used in conjunction with

speechreading, and a considerable

number of implanted individuals can

understand speech without visual clues.

Benefits have also been observed in

children including those who lost their

hearing prelingually.

The NIH sponsored a Consensus

Development Conference on Cochlear

Implants in 1988. Since then, implant

technology has been continually

improved. Questions unanswered at this

time have now been resolved. However,

new issues have emerged that must be

addressed. For example, the

performance of some severely to

profoundly hearing-impaired adults

using hearing aids is poorer than that of

even more severely hearing-impaired

individuals using cochlear implants

with advanced speech processing

strategies. Therefore, the criteria for

implantation should be re-examined.

Prediction of implant efficacy in a

specific individual remains a problem,

and agreement does not exist on the

definition of a successful implant user.

Surgical and other risks and possible

long-term effects of cochlear implants

require evaluation.

Implantation of individuals with

multiple disabilities, the elderly, and

children, particularly children who are

prelingually deaf, engender special

questions. What educational setting is

best for the development of speech and

language in children who are deaf and

have a cochlear implant? Are cochlear

implants efficacious in children who are

prelingually deaf?

This conference will bring together

specialists in auditory anatomy and

physiology, otolaryngology, audiology,

aural rehabilitation, education, speech

and language pathology and other

related disciplines as well as

representatives from the public.

After 11⁄2 days of presentations and

audience discussion, an independent,

non-Federal consensus panel will weigh

the scientific evidence and write a draft

statement that it will present to the

audience on the third day. The

consensus statement will address the

following key questions:

* What factors affect the auditory

performance of cochlear implant

recipients?

* What are the benefits and

limitations of cochlear implantation?

* What are the technical and safety

considerations of cochlear

implantation?

* Who is a candidate for cochlear

implantation?

* What are the directions for future

research on cochlear implantation?

The primary sponsors for this

conference are the National Institute on

Deafness and Other Communication

Disorders and the NIH Office of Medical

Applications of Research. The

conference is cosponsored by the

National Institute on Aging, the

National Institute of Child Health and

Human Development, and the National

Institute of Neurological Disorders and

Stroke. This is the 100th Consensus

Development Conference held by NIH

since the establishment of the

Consensus Development Program in

1977.

On the second day of the conference,

time has been allocated for 5-minute

formal oral presentations by concerned

individuals or organizations. Those

individuals or groups wishing to send a

representative to contribute during this

session must contact Ms. Elsa Bray by

5 p.m. eastern time, May 1, 1995 at:

Office of Medical Applications of

Research, National Institutes of Health,

Federal Building, Room 618, 7550

Wisconsin Avenue MSC9120, Bethesda,

Maryland 20892–9120, phone (301)

496–1144. If the number of requests

exceeds the slots available, presenters

will be chosen by lot, and those selected

will be notified by May 5, 1995.

Advance information on the

conference program and conference

registration materials may be obtained

from: Ann Besignano, Technical

Resources International, Inc., 3202

Tower Oaks Blvd., Suite 200, Rockville,

Maryland 20852, (301) 770–3153.

The consensus statement will be

submitted for publication in

professional journals and other

publications. In addition, the consensus

statement will be available beginning

May 17, 1995 from the NIH Consensus

Program Information Service, P.O. Box

2577, Kensington, Maryland 20891,